share_log

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Officer Kelly Jason R

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Officer Kelly Jason R

Ginkgo Bioworks | 4:持股变动声明-高管 Kelly Jason R
美股sec公告 ·  04/29 16:55
Moomoo AI 已提取核心信息
Ginkgo Bioworks Holdings, Inc. (DNA.US) has reported a transaction involving Jason R Kelly, a person with a remarked relationship to the issuer. The transaction, which took place on April 25, 2024, did not include any details regarding the number of shares, nature of shares, transaction price, or the total value of shares. Consequently, the number of shares held by Kelly after the transaction remains undisclosed.
Ginkgo Bioworks Holdings, Inc. (DNA.US) has reported a transaction involving Jason R Kelly, a person with a remarked relationship to the issuer. The transaction, which took place on April 25, 2024, did not include any details regarding the number of shares, nature of shares, transaction price, or the total value of shares. Consequently, the number of shares held by Kelly after the transaction remains undisclosed.
Ginkgo Bioworks Holdings, Inc.(DNA.US)报告了一笔涉及与发行人关系密切的人杰森·凯利的交易。该交易于2024年4月25日进行,不包括有关股票数量、股票性质、交易价格或股票总价值的任何细节。因此,凯利在交易后持有的股票数量仍未公开。
Ginkgo Bioworks Holdings, Inc.(DNA.US)报告了一笔涉及与发行人关系密切的人杰森·凯利的交易。该交易于2024年4月25日进行,不包括有关股票数量、股票性质、交易价格或股票总价值的任何细节。因此,凯利在交易后持有的股票数量仍未公开。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息